Integration of High Throughput ‘Omic Platforms into Antibody Discovery

Video   Dec 23, 2016

 

From antibodies to vaccines to T cells, cancer immunotherapy is extending patient lives. Targeted therapies using immune cell receptors can be targeted to either cancer or immune cells. In pursuit of lead structures, ‘omic technologies are revolutionizing the discovery and development of novel biological lead structures. However, ‘omic platforms are first and foremost data generation instruments that require careful integration into workflows. Here, we demonstrate how we have applied next-generation sequencing, big data, biostatistics, and computational immunology to the discovery and development of novel lead structures.

 
 
 
 

Recommended Videos

How Do Vaccines Work?

Video

Kelwalin Dhanasarnsombut details the science behind vaccines.

WATCH NOW

Tools for Gene Function Analysis

Video

LabTube Meets Catherine Goh, Head of Product Development and Marketing, SiTools Biotech GmbH.

WATCH NOW

Magnetic Beads Bind Sunblock Chemicals to Remove them from the Ocean

Video

Researchers use magnetic beads to mop up oxybenzone from the ocean and prevent coral bleaching.

WATCH NOW

 

Comments | 0 ADD COMMENT

Like what you just watched? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE